1. Home
  2. SCLX vs NTWK Comparison

SCLX vs NTWK Comparison

Compare SCLX & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$9.43

Market Cap

52.5M

Sector

Health Care

ML Signal

HOLD

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

HOLD

Current Price

$4.55

Market Cap

53.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
NTWK
Founded
2011
1997
Country
United States
United States
Employees
34
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
52.5M
53.7M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
SCLX
NTWK
Price
$9.43
$4.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
118.9K
32.7K
Earning Date
04-10-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
316.67
EPS
N/A
N/A
Revenue
N/A
$73,088,687.00
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.40
52 Week Low
$4.20
$2.73
52 Week High
$34.27
$5.75

Technical Indicators

Market Signals
Indicator
SCLX
NTWK
Relative Strength Index (RSI) 61.25 53.34
Support Level $7.73 $4.24
Resistance Level $9.44 $4.80
Average True Range (ATR) 0.97 0.22
MACD 0.24 -0.01
Stochastic Oscillator 75.84 60.00

Price Performance

Historical Comparison
SCLX
NTWK

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

Share on Social Networks: